The Mito Foundation's purpose is to end suffering from mitochondrial disease (mito). To reach that goal, we are working towards preventions, treatments, and cures for mito. We are also working to make these easily accessible to people with mito.
Our Research and Medical Grant Program drives research into mito. We do this by identifying and funding impactful research and clinical work. Read our research strategy to learn more. Today, Mito Foundation is the largest philanthropic funder of mito research in Australia. We have funded over 100 research grants.
Since 2010, we have supported researchers to make significant progress in mito research. Together, we are already improving the lives of people impacted by mito. Help us continue this important work by donating today.
We've invested
$9 million
in mito research worldwide
Research highlights from 2024
13 grants awarded across 4 research priority areas
Research funded across 5 countries
Identified a new mito gene, XRN1, improving genetic diagnostic rates
6 research studies made available to the Australian mito communityÂ
Research priority areas
We're committed to achieving the greatest impact for the mito community. To do this, we aim to fund the world's best mito research across 4 priority areas.

Understanding mito

Improving diagnosis

Improving health care

Advancing prevention, treatments, and cures

Understanding mito
Understanding the molecular and cellular processes involved in mito is essential. This is the foundation for much of mito research.
Since 2010, Mito Foundation has funded over 40 grants in this area of research. Discoveries from these projects are leading to advancements in:
- diagnosis
- prevention, treatments and cures.
Our funding has led to significant progress in understanding ultra-rare forms of mitochondrial diseases like Sengers Syndrome, Mohr-Tranbjaerg Syndrome, MEGCANN, and ATAD3-related mito. These studies offer hope for future treatments.
We funded the development of 2 new mouse models targeting forms of mito caused by the genes PTCD1 and TACO1. Our support has also advanced stem cell models for LHON and POLG-related mito. This research informs the development of effective treatments and therapies.

Improving diagnosis

Improving health care

Advancing prevention, treatments, and cures
"Early diagnosis has saved him from numerous related health conditions and possible death at an early age."
— Clare Hamman, Julian’s mum
Researcher journey
We regularly support researchers, and their teams, over many years, through multiple grants. This develops expertise and a stronger mito workforce. It also enables researchers to build on their discoveries. Over time, these research journeys have a great impact on the field of mito research and the mito community.
Associate Professor David Stroud's work pioneering a new diagnostic technique
Quantitative proteomics is a tool that has the potential to drastically improve mito diagnostic rates from around 50% toward 70%. Proteomics can be used to diagnose people who are still living without a diagnosis after traditional methods failed to provide an answer.
We've funded over
100
research grants
Contribute towards a brighter future for the mito community. Join the Mito Registry to be contacted about relevant clinical studies.
We offer a range of funding opportunities for research focussed on primary mitochondrial disease.
Our research strategy guides how we fund, facilitate, and influence research to drive meaningful progress.




